GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (OTCPK:PHRRF) » Definitions » Stock Based Compensation

PHRRF (PharmaTher Holdings) Stock Based Compensation : $0.00 Mil (TTM As of Nov. 2024)


View and export this data going back to 2020. Start your Free Trial

What is PharmaTher Holdings Stock Based Compensation?

PharmaTher Holdings's Stock Based Compensation for the three months ended in Nov. 2024 was $0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Nov. 2024 was $0.00 Mil.


PharmaTher Holdings Stock Based Compensation Historical Data

The historical data trend for PharmaTher Holdings's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings Stock Based Compensation Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23
Stock Based Compensation
0.34 0.29 -

PharmaTher Holdings Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 Aug24 Nov24
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PharmaTher Holdings Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.


PharmaTher Holdings Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaTher Holdings Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.